Skip to main content
Cidara Therapeutics, Inc. (CDTX)
NASDAQ: CDTX · IEX Real-Time Price · USD
12.51
-0.17 (-1.34%)
At close: May 3, 2024, 4:00 PM
12.00
-0.51 (-4.08%)
After-hours: May 3, 2024, 6:44 PM EDT

Cidara Therapeutics Revenue

In the year 2023, Cidara Therapeutics had annual revenue of $63.91M, a decrease of -0.84%. Revenue in the quarter ending December 31, 2023 was $17.58M with 69.41% year-over-year growth.

Revenue (ttm)
$63.91M
Revenue Growth
-0.84%
P/S Ratio
0.89
Revenue / Employee
$926,159
Employees
69
Market Cap
57.07M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202363.91M-543.00K-0.84%
Dec 31, 202264.45M14.88M30.01%
Dec 31, 202149.57M37.51M310.81%
Dec 31, 202012.07M-8.85M-42.30%
Dec 31, 201920.92M--
Dec 31, 20180--
Dec 31, 20170--
Dec 31, 20160--
Dec 31, 20150--
Dec 31, 20140--
Dec 31, 20130--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

CDTX News

More News